ScholarIQanswers from OpenAlex

Urologic and sexual morbidity following multimodality treatment for locally advanced primary and locally recurrent rectal cancer

PaperCitations, authors & open-access status

Urologic and sexual morbidity following multimodality treatment for locally advanced primary and locally recurrent rectal cancer is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Urologic and sexual morbidity following multimodality treatment for locally advanced primary and locally recurrent rectal cancer have?

ScholarIQcitation count

Urologic and sexual morbidity following multimodality treatment for locally advanced primary and locally recurrent rectal cancer has 101 citations in the OpenAlex counts ScholarIQ stores.

When was Urologic and sexual morbidity following multimodality treatment for locally advanced primary and locally recurrent rectal cancer published?

ScholarIQyear

Urologic and sexual morbidity following multimodality treatment for locally advanced primary and locally recurrent rectal cancer has 2001 year in the ScholarIQ index.

What is the open-access status of Urologic and sexual morbidity following multimodality treatment for locally advanced primary and locally recurrent rectal cancer?

ScholarIQoa status

Urologic and sexual morbidity following multimodality treatment for locally advanced primary and locally recurrent rectal cancer has closed oa status in the ScholarIQ index.

What is the DOI of Urologic and sexual morbidity following multimodality treatment for locally advanced primary and locally recurrent rectal cancer?

ScholarIQdoi

The DOI for Urologic and sexual morbidity following multimodality treatment for locally advanced primary and locally recurrent rectal cancer is on the source record.

What is the PMID of Urologic and sexual morbidity following multimodality treatment for locally advanced primary and locally recurrent rectal cancer?

ScholarIQpmid

The PMID for Urologic and sexual morbidity following multimodality treatment for locally advanced primary and locally recurrent rectal cancer is on the source record.

What is the OpenAlex record for Urologic and sexual morbidity following multimodality treatment for locally advanced primary and locally recurrent rectal cancer?

ScholarIQopenalex

The OpenAlex for Urologic and sexual morbidity following multimodality treatment for locally advanced primary and locally recurrent rectal cancer is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial